China Companion Diagnostic Tests in Oncology Market (2025-2031) | Size & Revenue, Segmentation, Forecast, Industry, Analysis, Outlook, Companies, Trends, Growth, Competitive Landscape, Share, Value

Market Forecast By Detection Technique (DNA Detection, Others), By Biomarker (EGFR, KRAS, HER2, BRAF V600E, Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Liver Cancer, Melanoma, Others), By End-user (Hospitals, Specialty Clinics, Diagnostic Labs, Others) And Competitive Landscape
Product Code: ETC6740153 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • China Companion Diagnostic Tests in Oncology Market Outlook
  • Market Size of China Companion Diagnostic Tests in Oncology Market, 2024
  • Forecast of China Companion Diagnostic Tests in Oncology Market, 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Revenues & Volume for the Period 2021- 2031
  • China Companion Diagnostic Tests in Oncology Market Trend Evolution
  • China Companion Diagnostic Tests in Oncology Market Drivers and Challenges
  • China Companion Diagnostic Tests in Oncology Price Trends
  • China Companion Diagnostic Tests in Oncology Porter's Five Forces
  • China Companion Diagnostic Tests in Oncology Industry Life Cycle
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Detection Technique for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By DNA Detection for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Biomarker for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By EGFR for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By KRAS for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By HER2 for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By BRAF V600E for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Cancer Type for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Melanoma for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By End-user for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Diagnostic Labs for the Period 2021- 2031
  • Historical Data and Forecast of China Companion Diagnostic Tests in Oncology Market Revenues & Volume By Others for the Period 2021- 2031
  • China Companion Diagnostic Tests in Oncology Import Export Trade Statistics
  • Market Opportunity Assessment By Detection Technique
  • Market Opportunity Assessment By Biomarker
  • Market Opportunity Assessment By Cancer Type
  • Market Opportunity Assessment By End-user
  • China Companion Diagnostic Tests in Oncology Top Companies Market Share
  • China Companion Diagnostic Tests in Oncology Competitive Benchmarking By Technical and Operational Parameters
  • China Companion Diagnostic Tests in Oncology Company Profiles
  • China Companion Diagnostic Tests in Oncology Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the China Companion Diagnostic Tests in Oncology Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the China Companion Diagnostic Tests in Oncology Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 China Companion Diagnostic Tests in Oncology Market Overview

3.1 China Country Macro Economic Indicators

3.2 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, 2021 & 2031F

3.3 China Companion Diagnostic Tests in Oncology Market - Industry Life Cycle

3.4 China Companion Diagnostic Tests in Oncology Market - Porter's Five Forces

3.5 China Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Detection Technique, 2021 & 2031F

3.6 China Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Biomarker, 2021 & 2031F

3.7 China Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

3.8 China Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By End-user, 2021 & 2031F

4 China Companion Diagnostic Tests in Oncology Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in China

4.2.2 Growing adoption of personalized medicine in oncology

4.2.3 Rising demand for targeted therapies in cancer treatment

4.3 Market Restraints

4.3.1 Regulatory challenges in companion diagnostic test approvals

4.3.2 Limited reimbursement policies for companion diagnostic tests in China

4.3.3 High cost associated with companion diagnostic tests

5 China Companion Diagnostic Tests in Oncology Market Trends

6 China Companion Diagnostic Tests in Oncology Market, By Types

6.1 China Companion Diagnostic Tests in Oncology Market, By Detection Technique

6.1.1 Overview and Analysis

6.1.2 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Detection Technique, 2021- 2031F

6.1.3 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By DNA Detection, 2021- 2031F

6.1.4 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.2 China Companion Diagnostic Tests in Oncology Market, By Biomarker

6.2.1 Overview and Analysis

6.2.2 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By EGFR, 2021- 2031F

6.2.3 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By KRAS, 2021- 2031F

6.2.4 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By HER2, 2021- 2031F

6.2.5 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By BRAF V600E, 2021- 2031F

6.2.6 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.3 China Companion Diagnostic Tests in Oncology Market, By Cancer Type

6.3.1 Overview and Analysis

6.3.2 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.3.3 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.3.4 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.3.5 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.3.6 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Melanoma, 2021- 2031F

6.3.7 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

6.4 China Companion Diagnostic Tests in Oncology Market, By End-user

6.4.1 Overview and Analysis

6.4.2 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.4 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Diagnostic Labs, 2021- 2031F

6.4.5 China Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F

7 China Companion Diagnostic Tests in Oncology Market Import-Export Trade Statistics

7.1 China Companion Diagnostic Tests in Oncology Market Export to Major Countries

7.2 China Companion Diagnostic Tests in Oncology Market Imports from Major Countries

8 China Companion Diagnostic Tests in Oncology Market Key Performance Indicators

8.1 Adoption rate of personalized medicine in oncology

8.2 Number of clinical trials incorporating companion diagnostic tests

8.3 Investment in research and development for companion diagnostic technologies

8.4 Number of partnerships between diagnostic companies and pharmaceutical firms

8.5 Rate of integration of companion diagnostic tests in standard cancer treatment protocols

9 China Companion Diagnostic Tests in Oncology Market - Opportunity Assessment

9.1 China Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Detection Technique, 2021 & 2031F

9.2 China Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Biomarker, 2021 & 2031F

9.3 China Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

9.4 China Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By End-user, 2021 & 2031F

10 China Companion Diagnostic Tests in Oncology Market - Competitive Landscape

10.1 China Companion Diagnostic Tests in Oncology Market Revenue Share, By Companies, 2024

10.2 China Companion Diagnostic Tests in Oncology Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All